Key result
Clinical nomogram predicts 5-year impaired fasting glucose risk with up to ~92% validation accuracy.
Why the study?
Tools for the early detection and 5-year risk prediction of impaired fasting glucose in Chinese adults were needed given its link to various diseases.
Can a nomogram based on routine individual characteristics accurately predict the 5-year risk of impaired fasting glucose in Chinese adults?
Cohort (n=28,875)
Yes
Can a nomogram based on routine individual characteristics accurately predict the 5-year risk of impaired fasting glucose in Chinese adults?
Answers are grounded in this paper and cite their sources.
A newly developed nomogram using routine clinical parameters accurately predicts the 5-year risk of impaired fasting glucose, offering a practical screening tool for primary healthcare.
Introduction This study aimed to develop a nomogram for early detection of impaired fasting glucose (IFG), predicting the 5-year risk in Chinese adults due to its link to various diseases. Materials and methods This retrospective cohort study included 28,875 participants without IFG at baseline, randomly divided them to a training set and a validation set. We developed four predictive models—LASSO, full, stepwise, and MFP—ultimately selecting the LASSO model for nomogram development due to its simplicity and predictive performance. Four prediction model performance was assessed through ROC analysis, calibration curves, and decision curve analysis, with external validation using Shunde Hospital (n = 18,618) and NHANES (n = 2,038) dataset. Results We developed a nomogram to predict the risk of IFG by incorporating parameters including age, body mass index (BMI), systolic blood pressure (SBP), fasting plasma glucose (FPG), and triglycerides (TG), which demonstrated performance with AUCs of 0.8167 and 0.8155 in the training and validation set, respectively. External validation achieved AUC 0.9665 (Shunde Hospital dataset) and 0.9171 (NHANES). Conclusions Our nomogram provides a personalized, validated approach for assessing 5-year IFG risk in Chinese adults, offering a practical screening tool for primary healthcare and resource-constrained environments.
No takes yet. Share an insight, caveat, or question.
Yijun et al. (2025) conducted a cohort in Impaired fasting glucose (n=28,875). LASSO-based predictive nomogram was evaluated on 5-year risk of impaired fasting glucose (AUC 0.8167). A nomogram incorporating age, BMI, SBP, FPG, and TG predicted the 5-year risk of impaired fasting glucose with an AUC of 0.8167 in the training set and 0.9171-0.9665 in external validation cohorts.
Synapse has enriched 10 related papers. Consider them for comparative context: